Mala Murthy is recorded as CEO at Teladoc Health, Inc. (TDOC), CFO at Trinet Group, Inc. (TNET) and Board Member at Avantor, Inc. (AVTR) since January 1, 2021. The newest filing on record that lists Mala Murthy as CEO at Teladoc Health, Inc. (TDOC) is dated April 8, 2025. The newest filing on record that lists Mala Murthy as CFO at Trinet Group, Inc. (TNET) is dated April 15, 2026. Trinet Group, Inc. reported in an 8-K filed October 29, 2025 that Mala Murthy was appointed Chief Financial Officer and Executive Vice-President, effective November 28, 2025. Teladoc Health, Inc. reported in an 8-K filed October 23, 2025 that Mala Murthy resigned as Chief Financial Officer, effective November 21, 2025. Teladoc Health, Inc. reported in an 8-K filed April 5, 2024 that Mala Murthy was appointed acting Chief Executive Officer, effective April 5, 2024. The proxy statement of Trinet Group, Inc. reports total compensation of $5,242,062 for Mala Murthy in fiscal 2025, including a base salary of $54,167. Disclosed compensation is on record for 5 fiscal years. Mala Murthy has spoken on 26 earnings calls and 1 other investor event across 2 companies, most recently for Trinet Group, Inc. on July 30, 2026. Those appearances were for Teladoc Health, Inc. (TDOC) and Trinet Group, Inc. (TNET). Teladoc Health, Inc. is classified in the Health Information Services industry within the Healthcare sector. Trinet Group, Inc. is classified in the Staffing & Employment Services industry within the Industrials sector. Other leadership on record at Teladoc Health, Inc. includes Charles "Chuck" Divita, III (CEO and Board Member), Charles Divita (CEO), Charles Divita, III (CEO and Board Member) and 7 others.
“On October 23, 2025, the Company's Board of Directors (the “Board”) appointed Ms. Mala Murthy as the Chief Financial Officer and Executive Vice-President of the Company, effective November 28, 2025 (the “Effective Date”).”
Trinet Group, Inc. Form 8-K, filed October 29, 2025
· Read the filing
“On October 17, 2025, Ms. Mala Murthy, Chief Financial Officer of the Company, informed the Company of her decision to resign, effective November 21, 2025, to pursue another career opportunity outside of the healthcare industry.”
Teladoc Health, Inc. Form 8-K, filed October 23, 2025
· Read the filing
Mala Murthy on recent calls
“I'm pleased with Trinette's second quarter execution, which was characterized by disciplined pricing, better-than-expected insurance results, improved retention, prudent cost management, and solid financial results.”
“I'm pleased with the quarter we delivered. It was a solid quarter. Revenue was essentially in line with what we had provided for overall guidance for the year. We, from an earnings perspective, we deliver strong earnings.”
“While the macro environment in the first quarter was uneven, Trinet's solid financial results were driven by disciplined pricing, better-than-expected insurance performance, and strong execution.”
“Our fourth quarter and full year financial performance reflected the difficult macro business environment we faced throughout 2025. Over the last two years, the U.S. economy has experienced high medical cost inflation and low job growth, and Trinet could not escape the impact of these factors.”
“As Chuck outlined, we are executing well against our strategic priorities, and our third quarter results reflect that momentum with consolidated revenue of $626 million above the midpoint of of our guidance range.”
